Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Isaac Yi Kim
Institutions:
Korea University,
Yale Cancer Center,
Yale University
Observed institutions:
Rutgers, The State University of New Jersey,
Korea University,
Brown University,
Yale Cancer Center,
Yale University,
Rutgers Cancer Institute
show all 6
OpenAlex ID:
A5016976850
The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non–muscle invasive bladder cancer
2014
·
Ho Won Kang
, Dong-Un Tchey
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
13
Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis.
2022
·
Jerry Kong
, Benjamin Lichtbroun
, et al.
·
PubMed
·
11
Current Update on Prostate Cancer Immunotherapy
2023
·
Juliana E. Kim
, Kunwoo Lee
, et al.
·
Journal of Urologic Oncology
·
7
PDF
Management strategies for radio-recurrent prostate cancer: a comprehensive review
2024
·
Syed N. Rahman
, Hyung Suk Kim
, et al.
·
Translational Cancer Research
·
6
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy
2024
·
Isaac E. Kim
, Isaac E. Kim
, et al.
·
Prostate International
·
3
Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations
2022
·
Isaac E. Kim
, Daniel D. Kim
, et al.
·
BMC Urology
·
3
PDF
Face/off: phase-specific modeling of lineage plasticity using near-patient models in genitourinary cancers
2026
·
Zirui Fu
, Longjun Li
, et al.
·
Gene
·
2
Navigating the winding road toward precision prostate cancer care
2025
·
Syed Rahman
, Adith S. Arun
, et al.
·
Gene
·
2
Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States.
2024
·
Michael Leapman
, Jessica B. Long
, et al.
·
Journal of Clinical Oncology
·
2
A phase 1, open-label trial to evaluate feasibility and safety of intramural injection of belzupacap sarotalocan (AU-011) in non-muscle–invasive bladder cancer (NMIBC).
2023
·
Seth P. Lerner
, Trinity Bivalacqua
, et al.
·
Journal of Clinical Oncology
·
2
Systemic Treatments in Men with De Novo Metastatic Prostate Cancer
2026
·
Dong-Hoon Lim
, Anthony Zhang
, et al.
·
Urologic Clinics of North America
·
1
Moving the Needle in Managing Men with Advanced Prostate Cancer
2026
·
Isaac Yi Kim
·
Urologic Clinics of North America
Association between genomic classifier scores and initial management of localized prostate cancer in a population-based cohort in the United States.
2026
·
Michael Leapman
, Rong Wang
, et al.
·
Journal of Clinical Oncology
PDF
List of contributors
2024
·
Piyush K. Agarwal
, Shree Agrawal-Patel
, et al.
·
Elsevier eBooks
Multicenter considerations
2024
·
Rachel Passarelli
, Joshua Sterling
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
15
Citation count:
52
H-index:
4
I10-index:
2
Year
Topic
Type